Sotalol Hydrochloride Tablet
Product Images NDC 71610-074

6 FDA label images from Aphena Pharma Solutions - Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sotalol Hydrochloride (NDC 71610-074). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 80 mg (71610 0074 30)

Bottle Label 80 mg (71610 0074 30)
Label for Sotalol Hydrochloride (Sotalol HCl) tablets, 80 mg strength, with a package count of 30 tablets. The label indicates the product is repackaged by Aphena Pharma Solutions - Tennessee, LLC and originally manufactured by Apotex Inc., Toronto, Canada. It includes storage instructions and a notice that the drug is prescription only (RX Only). The label features NDC 71610-0074-30 and barcodes on both sides.*
FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Figure1.jpg (Figure1)

Figure1.jpg (Figure1)
A Kaplan-Meier survival curve chart comparing recurrence-free survival over 360 days among different doses of Sotalol Hydrochloride Tablets (80 mg, 120 mg, 160 mg) versus placebo. The y-axis shows recurrence-free survival probability, and the x-axis shows time in days. P-values for each dose compared to placebo are noted.*
FDA Label Image

Figure2.jpg (Figure2)

Figure2.jpg (Figure2)
A Kaplan-Meier survival curve comparing recurrence-free survival over time (days) between Sotalol Hydrochloride Tablets (AF) and placebo groups. The vertical axis shows recurrence-free survival probability, and the horizontal axis shows time in days, up to 180 days. The graph indicates a statistically significant difference with a log-rank p-value of 0.002, showing higher recurrence-free survival for the Sotalol Hydrochloride group compared to placebo.*
FDA Label Image

Structure (Sotalolhcl Af 01)

Structure (Sotalolhcl Af  01)
Chemical structure of Sotalol Hydrochloride showing its molecular composition including functional groups and the hydrochloride salt component.*
FDA Label Image

Age Factor (Sotalolhcl Af 04)

Age Factor (Sotalolhcl Af  04)
A line graph depicting Age Factor versus Age in months. The X-axis represents age in months ranging from 0.1 to 50, with a note that Age Factor equals 1 for age greater than 24 months. The Y-axis shows the Age Factor values from 0.0 to 1.0. The graph shows a curve starting near 0.2 and gradually increasing to 1.0 as age in months increases.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.